Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • cancer

    Tag: cancer

    You Searched For "cancer"
    US to wrap criminal trial of Insys Therapeutics

    US to wrap criminal trial of Insys Therapeutics' executives tied to opioid crisis

    Medical Dialogues Bureau6 April 2019 8:59 AM IST
    BOSTON: Prosecutors on Thursday will present their closing arguments in the trial of the wealthy founder of pharmaceutical company Insys Therapeutics...
    Emcure launches generic Eribulin at 40 percent lower price in India

    Emcure launches generic Eribulin at 40 percent lower price in India

    Farhat Nasim4 April 2019 9:30 AM IST
    Emcure Pharmaceuticals will manufacture Eribulin at its plant at Hinjewadi in Pune and market it at a cost which will be approximately 40 per cent...
    Novartis division resubmits USFDA application for biosimilar Pegfilgrastim

    Novartis division resubmits USFDA application for biosimilar Pegfilgrastim

    Farhat Nasim4 April 2019 9:15 AM IST
    New Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...
    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    Meghna A Singhania3 April 2019 4:30 PM IST
    New Delhi: After facing trouble with its baby talcum powder amid allegations that it contains asbestos, US healthcare giant Johnson and Johnson (JnJ)...
    USFDA issues warning letter to Rajasthan based homeopathic firm and 3 others

    USFDA issues warning letter to Rajasthan based homeopathic firm and 3 others

    Farhat Nasim3 April 2019 9:25 AM IST
    New Delhi: The U.S. Food and Drug Administration (USFDA) recently posted warning letters to four companies producing homoeopathic drug products for...
    Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief

    Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief

    Medical Dialogues Bureau29 March 2019 11:40 AM IST
    JnJ on Wednesday also settled three other mesothelioma talc cases pending in state courts in California, Oklahoma and New York, Chris Panatier, a...
    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    Garima29 March 2019 9:15 AM IST
    Under the deal, AstraZeneca will pay Daiichi up to $6.9 billion, including a $1.35 billion upfront payment. The two companies will share development...
    February has been a month of achievements, robust initiatives and success at AMRI Hospitals

    February has been a month of achievements, robust initiatives and success at AMRI Hospitals

    Medical Dialogues Bureau26 March 2019 9:05 AM IST
    New Delhi: With an utmost commitment towards delivering the best medical services, AMRI Hospitals, Bhubaneshwar, has always been at the forefront of...
    USFDA puts partial hold on Abbvie Venclexta clinical trials after deaths

    USFDA puts partial hold on Abbvie Venclexta clinical trials after deaths

    Farhat Nasim21 March 2019 9:45 AM IST
    The clinical hold does not impact any of the approved indications for Venclexta, such as chronic lymphocytic leukaemia (CLL) or acute myeloid...
    GSK reports positive data from trial of cancer drug Dostarlimab

    GSK reports positive data from trial of cancer drug Dostarlimab

    Garima21 March 2019 9:15 AM IST
    GSK said it would apply for marketing approval for Dostarlimab in endometrial cancer at the end of 2019.New Delhi: GlaxoSmithKline said on Tuesday a...
    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Meghna A Singhania17 March 2019 1:33 PM IST
    New Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
    US: Woman with cancer who used JnJ talcum powder awarded Rs 200 crore approx

    US: Woman with cancer who used JnJ talcum powder awarded Rs 200 crore approx

    Garima15 March 2019 10:05 AM IST
    JnJ said it would appeal, citing "serious procedural and evidentiary errors" in the course of the trial, saying lawyers for the woman had...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok